PENDANT AMINES AND DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

This present disclosure is directed to compounds of formula (I): (I) where R1a, R1b, R1c, R1d, R1e, R3, R4a, R4b, R4c, R4d, R6, R7, and R8 are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium i...

Full description

Saved in:
Bibliographic Details
Main Authors GUILFORD, WILLIAM, ROINESTAD, KURT, KIRKLAND, TOM, BHATT, LOPA, SPRINGMAN, ERIC
Format Patent
LanguageEnglish
French
Published 14.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This present disclosure is directed to compounds of formula (I): (I) where R1a, R1b, R1c, R1d, R1e, R3, R4a, R4b, R4c, R4d, R6, R7, and R8 are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions including the compounds described herein and methods of preparing the compounds described herein are also provided. La présente invention concerne des composés de formule (I) : (I) où R1a, R1b, R1c, R1d, R1e, R3, R4a, R4b, R4c, R4d, R6, R7, et R8 sont tels que décrits dans la description, en tant que stéréoisomères uniques ou en tant que mélanges de stéréoisomères, ou des sels pharmaceutiquement acceptables, des solvates, des clathrates, des polymorphes, des ions d'ammonium, des N-oxydes ou des promédicaments de ceux-ci ; qui sont des inhibiteurs de leucotriène A4 hydrolase et par conséquent sont utiles dans le traitement de troubles inflammatoires. L'invention concerne également des compositions pharmaceutiques comprenant les composés de la présente invention et des procédés de préparation de ces composés.
Bibliography:Application Number: CA20173045887